Key Metrics of Silicon Laboratories
Revenue$782M▼ 23.6% YoYFY 2023
Operating income−$24.2M▼ 120.3% YoY
Net profit−$34.5M▼ 137.8% YoY
Shareholders' equity$1.2B
Market cap$7.4BSLAB · $221.12
Competitors10identified
About Silicon Laboratories
Sectors
Company details
- Website
- silabs.com
- Founded
- 2000
- Listed
- Nasdaq: SLAB (since 2000)
Operational Areas of Silicon Laboratories
Pharmaceuticals & Healthcare›Formulations & Contract Manufacturing
Company summary
Legal nameSilicon Laboratories Inc.
TickerSLAB
ExchangeNasdaq
CountryUnited States
SEC CIK0001038074
Listed since2000
IndustrySemiconductors
SectorPharmaceuticals & Healthcare · Formulations & Contract Manufacturing
Websitehttp://www.silabs.com
US market & SEC filings
SLAB · Nasdaq · SEC CIK 0001038074
Last price · 23 Oct 2026
$221.12
−0.27%
Market cap$7.4B
P/E—On FY 2023 diluted EPS
Volume340,980
SectorTechnologySemiconductors
Country · IPOUnited StatesListed 2000
SLAB share price
Premium
Annual results (SEC EDGAR)
Revenue, operating income, net income, EPS, cash flow, assets, liabilities, equity and debt for every year filed with the SEC are part of the premium plan.
Sign in to continue See plans & pricingVendor checks & payment capacity
Sign in with access to company financials to review vendor evidence.
Registered office and contact
Registered officeAustin
GSTIN—
Email—
Websitehttp://www.silabs.com
Members / shareholders—
Directors and key people
Directors are read from the MGT-7 annual return and AOC-4 signatories.
Competitors of Silicon Laboratories
Competitors10identified
Countries1most in United States
Top competitors by location
| Company | Description | Domain | Founded | Location |
|---|---|---|---|---|
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | lilly.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | jjmt.com.tw | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | pg.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | merck.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | amgen.com | 1983 | United States | |
| Part of Gilead Sciences. | gilead.com | 1992 | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | abbott.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | pfizer.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | bms.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | marriott.com.cn | — | United States |
Charges (secured borrowings)
0 registered charges. Lenders, amounts and dates are part of the premium plan.
Statutory auditors
Auditors are read from the AOC-4 auditor's report section.
Group companies
Business activities and related parties
Principal business activities and related-party transactions are read from MGT-7 and AOC-4 filings.
Filings
No filings on record yet.